$1.50
-0.03-1.96%
Últ. Act.: Oct 19, 4:33 PM
$1.55
0.021.31%
BioRestorative Therapies (BRTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-6.00 | $-7.40 | $-7.60 | $-8.20 |
| Actual | $-2.40 | $-6.40 | $-6.60 | $-6.00 |
| Surprise | +60.0% | +13.5% | +13.2% | +26.8% |
| Revenue | ||||
| Estimate | $260000 | $170000 | $436000 | $284000 |
| Actual | $23170 | $19600 | $11800 | $303000 |
| Surprise | -91.1% | -88.5% | -97.3% | +6.69% |
| Metric | Q2 '26E | Q3 '26E | Q4 '26E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-2.92 | $-2.60 | $-2.60 |
| Revenue | |||
| Consensus | $70000 | $90000 | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q1 | May 14, 2026 | $-2.40 | $-6.00 | 60.0 % |
| Q4 | Mar 26, 2026 | $-6.40 | $-7.40 | 13.5 % |
| Q3 | Nov 12, 2025 | $-6.60 | $-7.60 | 13.2 % |
| Q2 | Aug 12, 2025 | $-6.00 | $-8.20 | 26.8 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q1 | May 14, 2026 | $23.17K | $260.00K | -91.1 % |
| Q4 | Mar 26, 2026 | $19.60K | $170.00K | -88.5 % |
| Q3 | Nov 12, 2025 | $11.80K | $436.00K | -97.3 % |
| Q2 | Aug 12, 2025 | $303.00K | $284.00K | 6.69 % |